226 related articles for article (PubMed ID: 7555530)
1. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
3. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
[TBL] [Abstract][Full Text] [Related]
4. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz HE; Wiegmann TB; Cnaan A; Shahinfar S; Sica DA; Broadstone V; Schwartz SL; Mengel MC; Segal R; Versaggi JA
Kidney Int Suppl; 1994 Feb; 45():S150-5. PubMed ID: 8158885
[TBL] [Abstract][Full Text] [Related]
5. The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM.
Chan JC; Yeung VT; Leung DH; Tomlinson B; Nicholls MG; Cockram CS
Diabetes Care; 1994 Aug; 17(8):859-62. PubMed ID: 7956631
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
Josefsberg Z; Ross SA; Lev-Ran A; Hwang DL
Diabetes Care; 1995 May; 18(5):690-3. PubMed ID: 8586009
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
Sano T; Kawamura T; Matsumae H; Sasaki H; Nakayama M; Hara T; Matsuo S; Hotta N; Sakamoto N
Diabetes Care; 1994 May; 17(5):420-4. PubMed ID: 8062609
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.
Moore MP; Elliott TW; Nicholls MG
Diabetes Care; 1988 May; 11(5):397-401. PubMed ID: 2839322
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.
Chan JC; Cockram CS; Nicholls MG; Cheung CK; Swaminathan R
BMJ; 1992 Oct; 305(6860):981-5. PubMed ID: 1458144
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
[TBL] [Abstract][Full Text] [Related]
11. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
DeQuattro V; Lee DP
Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
[TBL] [Abstract][Full Text] [Related]
12. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Gavras I; Gavras H
Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.
Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
Diabetes Care; 1991 Oct; 14(10):911-4. PubMed ID: 1773691
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
Baba T; Murabayashi S; Takebe K
Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
[TBL] [Abstract][Full Text] [Related]
15. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy].
Andronico G; Carone MB; Mulè G; Mangano MT; Cerasola G
Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1161-4. PubMed ID: 2100527
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
Ueda Y; Aoi W; Yamachika S; Shikaya T
Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
[TBL] [Abstract][Full Text] [Related]
18. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA
Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
Hoogenberg K; Navis G; Dullaart RP
Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
[TBL] [Abstract][Full Text] [Related]
20. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
